TrialBritish journal of pharmacology2012

Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti-MRSA fluoroquinolone JNJ-Q2.

G Eichenbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.